{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:23:46Z","timestamp":1790742226435,"version":"4.1.0"},"reference-count":36,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>In the context of the menopausal transition, genitourinary syndrome of menopause (GSM) refers to a range of genitourinary symptoms, from vaginal dryness to dysuria and urinary urgency. While hormonal treatments are standard, their associated side effects have driven the exploration of alternatives like vaginal CO2 laser. We aimed to evaluate the randomized controlled trials (RCTs) comparing vaginal CO2 laser treatment for GSM to sham controls. This systematic review sourced four electronic databases until June 2023. The analysis incorporated seven RCTs with 407 women. The CO2 laser and sham control were comparable for most parameters, including the female sexual function index (FSFI) and visual analogue scale (VAS) for dyspareunia, vaginal health index, pH, and patient satisfaction. However, the CO2 laser group showed significant improvement in the vaginal assessment scale for GSM symptoms. Sensitivity analyses revealed that parameters like FSFI showed significant differences in favor of CO2 laser group upon the exclusion of specific studies. In conclusion, vaginal CO2 laser therapy emerges as a promising alternative for GSM management, especially for most bothersome GSM symptoms; however, the need for further well-designed RCTs remains to validate its broad safety and efficacy.<\/jats:p>","DOI":"10.3390\/jpm13121694","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:47:30Z","timestamp":1702014450000},"page":"1694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CO2 Laser versus Sham Control for the Management of Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3390","volume":"13","author":[{"given":"Anastasia","family":"Prodromidou","sequence":"first","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Zacharakis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Athanasiou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0031-809X","authenticated-orcid":false,"given":"Nikolaos","family":"Kathopoulis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8725-7103","authenticated-orcid":false,"given":"Antonia","family":"Varthaliti","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Douligeris","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-9776","authenticated-orcid":false,"given":"Lina","family":"Michala","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veatriki","family":"Athanasiou","sequence":"additional","affiliation":[{"name":"Medicine, Brighton and Sussex Medical School, Brighton BN1 9PX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Salvatore","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, IRRCS San Raffaele Hospital, Vita-Salute San Raffaele University, 20125 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themos","family":"Grigoriadis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13697137.2017.1421921","article-title":"Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study","volume":"21","author":"Moral","year":"2018","journal-title":"Climacteric"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2021.06.005","article-title":"Vaginal laser therapy for genitourinary syndrome of menopause\u2014Systematic review","volume":"156","author":"Mension","year":"2022","journal-title":"Maturitas"},{"key":"ref_4","first-page":"e7586","article-title":"The Genitourinary Syndrome of Menopause: An Overview of the Recent Data","volume":"12","author":"Angelou","year":"2020","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ruffolo, A.F., Braga, A., Torella, M., Frigerio, M., Cimmino, C., De Rosa, A., Sorice, P., Castronovo, F., Salvatore, S., and Serati, M. (2022). Vaginal Laser Therapy for Female Stress Urinary Incontinence: New Solutions for a Well-Known Issue\u2014A Concise Review. Medicina, 58.","DOI":"10.3390\/medicina58040512"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2018.08.008","article-title":"Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials","volume":"229","author":"Pitsouni","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2232563","DOI":"10.1001\/jamanetworkopen.2022.32563","article-title":"Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis","volume":"5","author":"Jang","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/GME.0000000000001845","article-title":"Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: A systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khamis","year":"2021","journal-title":"Menopause"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2020.10.018","article-title":"Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors","volume":"144","author":"Quick","year":"2021","journal-title":"Maturitas"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/GME.0000000000001542","article-title":"Treatment for vaginal atrophy using microablative fractional CO2 laser: A randomized double-blinded sham-controlled trial","volume":"27","author":"Ruanphoo","year":"2020","journal-title":"Menopause"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jsxm.2021.01.188","article-title":"A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause","volume":"18","author":"Cruff","year":"2021","journal-title":"J. Sex Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial","volume":"326","author":"Li","year":"2021","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13697137.2020.1829584","article-title":"CO2 laser and the genitourinary syndrome of menopause: A randomized sham-controlled trial","volume":"24","author":"Salvatore","year":"2021","journal-title":"Climacteric"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2255697","DOI":"10.1001\/jamanetworkopen.2022.55697","article-title":"Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial","volume":"6","author":"Mension","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1471-0528.17335","article-title":"Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial","volume":"130","author":"Page","year":"2023","journal-title":"Bjog"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: An update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hozo, S.P., Djulbegovic, B., and Hozo, I. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol., 5.","DOI":"10.1186\/1471-2288-5-13"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10103-021-03260-x","article-title":"A randomized controlled study of vaginal fractional CO2 laser therapy for female sexual dysfunction","volume":"37","author":"Lou","year":"2022","journal-title":"Lasers Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"278.e271","DOI":"10.1016\/j.ajog.2023.05.005","article-title":"Vaginal epithelial histology before and after fractional CO2 laser in postmenopausal women: A double-blind, sham-controlled randomized trial","volume":"229","author":"Li","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","journal-title":"Menopause"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/GME.0000000000001797","article-title":"Comparison of topical fractional CO2 laser and vaginal estrogen for the treatment of genitourinary syndrome in postmenopausal women: A randomized controlled trial","volume":"28","author":"Dutra","year":"2021","journal-title":"Menopause"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: A randomized clinical trial","volume":"26","author":"Politano","year":"2019","journal-title":"Menopause"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lsm.23220","article-title":"Efficacy of Fractional CO2 Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial","volume":"52","author":"Aguiar","year":"2020","journal-title":"Lasers Surg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.mayocp.2017.08.019","article-title":"Genitourinary Syndrome of Menopause: Management Strategies for the Clinician","volume":"92","author":"Faubion","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jugulyt\u0117, N., \u017dukien\u0117, G., and Bartkevi\u010dien\u0117, D. (2023). Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina, 59.","DOI":"10.3390\/medicina59010132"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/0284186X.2023.2238548","article-title":"Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: A 12-year longitudinal follow-up study and comparison with the general female population","volume":"62","author":"Raj","year":"2023","journal-title":"Acta Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","article-title":"The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis","volume":"19","author":"Jha","year":"2019","journal-title":"Clin. Breast Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00432-018-2614-8","article-title":"Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment","volume":"144","author":"Mothes","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/1471-0528.17489","article-title":"Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial\u2009-\u2009Some crucial criticalities","volume":"130","author":"Salvatore","year":"2023","journal-title":"Bjog"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2017.07.007","article-title":"CO2-laser for the genitourinary syndrome of menopause. How many laser sessions?","volume":"104","author":"Athanasiou","year":"2017","journal-title":"Maturitas"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10103-017-2293-8","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: Power of 30 or 40 W?","volume":"32","author":"Pitsouni","year":"2017","journal-title":"Lasers Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jsxm.2021.12.010","article-title":"CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis","volume":"19","author":"Filippini","year":"2022","journal-title":"J. Sex Med."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/12\/1694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:18Z","timestamp":1760132118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/12\/1694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["jpm13121694"],"URL":"https:\/\/doi.org\/10.3390\/jpm13121694","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]}}}